AstraZeneca to upgrade US listing in ‘knock-back for London’

UK’s biggest drugmaker to put its US shares on par with its London-based stock, but says HQ will stay in Cambridge GSK’s Emma Walmsley to be replaced as CEO Business live – latest updates...

Redirecting to full article...